Researchers exploring the development of mucosal vaccines for respiratory viruses

NIH experts provide perspective on next-generation methods. It has been extremely difficult to create vaccines that offer long-lasting protection from influenza, coronaviruses and respiratory syncytial viruses (RSV). In a review article published in cell host & microbe by researchers at the National Institute of Allergy and Infectious Diseases, part of the NIH explores the challenges and outlines approaches […]

FDA Approves Label Update for Novo Nordisk’s Rybelsus, Allowing First-Line Use in Adults with Type 2 Diabetes

The U.S. Food and Drug Administration has approved an update to the label for Rybelsus tablets (7 mg or 14mg) that allows adults with type-2 diabetes who have never taken diabetes medication before, to use it as their first line treatment. The FDA has approved a label update that removes an old restriction of use stating […]

FDA Approves Airsupra (Albuterol and Budesonide) Inhalation Aerosol for On-Demand Treatment of Bronchoconstriction and Asthma

The FDA has approved Airsupra inhalation aerosol (albuterol budesonide), for use in the treatment of bronchoconstriction or prevention, and to reduce asthma attacks among asthmatics 18 years and older. Airsupra combines albuterol, a beta-2-adrenergic receptor agonist (and corticosteroid), with budesonide. Airsupra, a combination of inhaled corticosteroid and short-acting -agonist, is the U.S.’s first product containing ICS […]

Real-World Potential Seen in Promising Candidate for Whole-Sporozoite Malaria Vaccine

A report in Science Translational Medicine found that an experimental malaria vaccine containing whole inactivated Plasmodium Falciparumsporozoites decreased the risk of infection in adults living in a malaria endemic area. In a 5-dose regimen with a lower concentration, the vaccine had previously shown greater than 90 percent vaccine efficacy in controlled infections and 52 percent vaccine efficacy in […]

New Causal Biomarkers of Atherosclerotic Coronary Artery Disease (ASCAD) Identified in Published Results by Aitia and G3 Therapeutics

G3 Therapeutics (a life sciences company) that uses large-scale, multi-omic, biological big data for the development of life-changing diagnostics and therapeutics, as well as Aitia (the leader in the use of Causal Artificial Intelligence and “Digital Twins”, to discover and create new drugs), announced today the results of a research project that identified new ASCAD […]

Potential treatment for long-term COVID-19-related smell loss using nasal injections

Researchers at Stanford Medicine conducted a study in which more than half the patients who had persistent smell loss improved with platelet-rich blood plasma injections. Zara Patel MD was there when COVID-19 patients began to report that their sense of odor had been affected. Patel, a professor of otolaryngology in Stanford Medicine, has studied the loss […]

Safety of COVID-19 Vaccine for Children with MIS-C Appears Promising

A study supported by the NIH found no serious complications after rare immune conditions. In a study of children who had received a COVID-19 vaccine following the multisystem inflammatory disorder (MIS-C), there were no serious complications reported, including myocarditis and recurrence of MIS-C. Around half of participants had mild reactions such as fatigue and arm pain. The […]